GPT Healthcare Ltd Stock Price Today (NSE: GPTHEALTH)
Fundamental Score
GPT Healthcare Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
GPT Healthcare Ltd share price today is ₹129.28, up +0.00% on NSE/BSE as of 17 February 2026. GPT Healthcare Ltd (GPTHEALTH) is a Small-cap company in the Hospital sector with a market capitalisation of ₹1.15K (Cr). The 52-week high for GPTHEALTH share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 26.40x, GPTHEALTH is currently trading below its industry average P/E of 52.84x. The company has a Return on Equity (ROE) of 21.30% and a debt-to-equity ratio of 0.38.
GPT Healthcare Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
GPT Healthcare Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
GPT Healthcare Share Price: A ROCE-Driven Analysis
The healthcare sector, specifically the hospital segment, is undergoing a significant shift. It is seeing a transition from pure volume-based revenue models to focusing on higher-margin specialties and operational efficiencies. This shift makes metrics like Return on Capital Employed (ROCE) increasingly critical for investors. Our analysis focuses on GPT Healthcare share price (₹128.5) in light of its ROCE performance. Currently, the stock trades at a PE ratio of 26.4 with a ROCE of 27.23%. This analysis is part of a larger 80-parameter fundamental audit verified by Sweta Mishra.
GPT Healthcare's impressive ROCE of 27.23% suggests efficient capital allocation and strong profitability relative to the capital employed. This high ROCE contributes to the development of an economic moat, making it harder for competitors to erode their market share. It signals that the company is likely generating healthy returns on its investments and possesses a competitive advantage, perhaps through operational efficiencies, specialized service offerings, or a strong regional presence.
Comparing GPT Healthcare to its peers is crucial. For instance, while
Nephro Care India Limited also operates in the healthcare space, a qualitative comparison of management quality becomes relevant. If GPT Healthcare's management demonstrates superior capital allocation skills, consistently driving higher ROCE, it may justify a premium valuation compared to peers with lower operational efficiency, even if their PE ratios appear similar. A closer look at how Nephro Care India Limited compares in terms of strategic execution and financial discipline will provide more depth to the analysis.The current PE ratio of 26.4 should be viewed in conjunction with the ROCE. A high ROCE can potentially justify a higher PE ratio, as it indicates the company's ability to generate future earnings growth efficiently. Further investigation into the sustainability of this ROCE is important. Factors such as regulatory changes, competition, and changes in healthcare spending patterns could impact future ROCE. The analysis provides an observation of key financial metrics, and should not be considered as investment advice.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
GPT Healthcare Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of GPTHEALTH across key market metrics for learning purposes.
Positive Indicators
10 factors identified
Strong Return on Equity (21.30%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (27.23%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (21.09%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 26.40 vs Industry: 52.84)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Consistent Growth Track Record (13.96% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (34.94% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Strong Interest Coverage (11.63x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹222.08 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (65.57%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
3 factors identified
Profit Decline Concern (-28.48%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Weak Earnings Growth (-0.44% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Limited Institutional Interest (FII+DII: 9.65%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
GPT Healthcare Ltd Financial Statements
Comprehensive financial data for GPT Healthcare Ltd including income statement, balance sheet and cash flow
About GPTHEALTH (GPT Healthcare Ltd)
GPT Healthcare Ltd (GPTHEALTH) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Hospital sector with a current market capitalisation of ₹1.15K (Cr). GPT Healthcare Ltd has delivered a Return on Equity (ROE) of 21.30% and a ROCE of 27.23%. The debt-to-equity ratio stands at 0.38, reflecting the company's capital structure. Investors tracking GPTHEALTH share price can monitor key metrics including P/E ratio, promoter holding of 65.57%, and quarterly earnings growth.
Company Details
Key Leadership
Corporate Events
GPTHEALTH Share Price: Frequently Asked Questions
What is the current share price of GPT Healthcare Ltd (GPTHEALTH)?
As of 17 Feb 2026, 10:10 am IST, GPT Healthcare Ltd share price is ₹129.28. The GPTHEALTH stock has a market capitalisation of ₹1.15K (Cr) on NSE/BSE.
Is GPTHEALTH share price Overvalued or Undervalued?
GPTHEALTH share price is currently trading at a P/E ratio of 26.40x, compared to the industry average of 52.84x. Based on this relative valuation, the GPT Healthcare Ltd stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of GPTHEALTH share price?
The 52-week high of GPTHEALTH share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the GPT Healthcare Ltd share price?
Key factors influencing GPTHEALTH share price include quarterly earnings growth (Sales Growth: 12.54%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is GPT Healthcare Ltd a good stock for long-term investment?
GPT Healthcare Ltd shows a 5-year Profit Growth of 34.94% and an ROE of 21.30%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.38 before investing in GPTHEALTH shares.
How does GPT Healthcare Ltd compare with its industry peers?
GPT Healthcare Ltd competes with major peers in the Hospital. Investors should compare GPTHEALTH share price P/E of 26.40x and ROE of 21.30% against the industry averages to determine competitive standing.
What is the P/E ratio of GPTHEALTH and what does it mean?
GPTHEALTH share price has a P/E ratio of 26.40x compared to the industry average of 52.84x. Investors pay ₹26 for every ₹1 of annual earnings.
How is GPTHEALTH performing according to Bull Run's analysis?
GPTHEALTH has a Bull Run fundamental score of 61/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does GPTHEALTH belong to?
GPTHEALTH operates in the Hospital industry. This classification helps understand the competitive landscape and sector-specific trends affecting GPT Healthcare Ltd share price.
What is Return on Equity (ROE) and why is it important for GPTHEALTH?
GPTHEALTH has an ROE of 21.30%, which indicates excellent management efficiency. ROE measures how efficiently GPT Healthcare Ltd generates profits from shareholders capital.
How is GPTHEALTH debt-to-equity ratio and what does it indicate?
GPTHEALTH has a debt-to-equity ratio of 0.38, which indicates moderate leverage that should be monitored.
What is GPTHEALTH dividend yield and is it a good dividend stock?
GPTHEALTH offers a dividend yield of 1.79%, meaning you receive ₹1.79 annual dividend for every ₹100 invested in GPT Healthcare Ltd shares.
How has GPTHEALTH share price grown over the past 5 years?
GPTHEALTH has achieved 5-year growth rates of: Sales Growth 13.96%, Profit Growth 34.94%, and EPS Growth -0.44%.
What is the promoter holding in GPTHEALTH and why does it matter?
Promoters hold 65.57% of GPTHEALTH shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in GPT Healthcare Ltd.
What is GPTHEALTH market capitalisation category?
GPTHEALTH has a market capitalisation of ₹1146 crores, placing it in the Small-cap category.
How volatile is GPTHEALTH stock?
GPTHEALTH has a beta of N/A. A beta > 1 suggests the GPT Healthcare Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is GPTHEALTH operating profit margin trend?
GPTHEALTH has a 5-year average Operating Profit Margin (OPM) of 21.09%, indicating the company's operational efficiency.
How is GPTHEALTH quarterly performance?
Recent quarterly performance shows GPT Healthcare Ltd YoY Sales Growth of 12.54% and YoY Profit Growth of -28.48%.
What is the institutional holding pattern in GPTHEALTH?
GPTHEALTH has FII holding of 3.20% and DII holding of 6.45%. Significant institutional holding often suggests professional confidence in the GPT Healthcare Ltd stock.